ArticleMolecular medicine (Cambridge, Mass.)2025
Bulk and single-cell transcriptome analysis reveal shared key genes and patterns of immune dysregulation in systemic lupus erythematosus and sepsis.
Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Systemic lupus erythematosus (SLE) patients often experience sepsis, a significant clinical challenge that frequently requires intensive care and contributes significantly to morbidity and mortality. However, the molecular mechanisms underlying this comorbidity remain poorly understood. This study investigated the molecular intersection of SLE and sepsis using publicly available gene expression datasets. We identified 93 differentially expressed genes (DEGs) (49 upregulated and 44 downregulated) shared by both conditions, primarily impacting bacterial defense and immune response pathways. Integrated differential expression and weighted gene co-expression network analyses (WGCNA) revealed 11 hub genes, with TNFAIP6 and PLSCR1 showing significant diagnostic potential. Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) revealed a significant expansion of CD14+ monocytes in both conditions, exhibiting elevated expression of the identified hub genes and similar transcriptional profiles. Upregulation of TNFAIP6 and PLSCR1 was validated using public monocyte datasets and real-time PCR of mouse PBMCs, with PLSCR1 showing markedly increased expression in SLE cases complicated by sepsis. Our findings demonstrate that CD14+ monocytes emerge as a common site of immune dysregulation in these comorbid conditions, with overlapping gene expression and pathway alterations suggesting shared molecular mechanisms that could inform targeted therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.